Viral Diseases Tester Virax Biolabs Prices Upsized US$6.75 Million IPO
Biopharmaceutical company Virax Biolabs Group Limited recently increased its initial public offering size as it applies for a Nasdaq Capital
Read moreBiopharmaceutical company Virax Biolabs Group Limited recently increased its initial public offering size as it applies for a Nasdaq Capital
Read more